Printer Friendly

ANERGEN REPORTS SECOND QUARTER RESULTS

 REDWOOD CITY, Calif., July 22 /PRNewswire/ -- Anergen Inc. (NASDAQ: ANRG) today reported a net loss of $1,804,000, or $.32 per share, for the second quarter ended June 30, 1993, as compared to a loss of $1,252,000, or $.22 per share, for the same period a year ago. Anergen's loss for the six-month period ended June 30, 1993, was $3,352,000, or $.59 per share, as compared to a loss of $2,374,000, or $.43 per share, for the six months ended June 30, 1992.
 John W. Varian, Anergen's chief financial officer, said, "The company's scientific plan is progressing and is at planned spending levels. The increase in expenditures reflects the costs of production in our pilot manufacturing facility which was completed in late 1992."
 Anergen is developing therapies for the treatment of autoimmune diseases


using proprietary biopharmaceutical compounds designed to inactivate or anergize only the specific T cells in the immune system responsible for each disease.
 ANERGEN INC.
 Unaudited Selected Financial Data
 (In thousands except per share data)
 Three Months Ended Six Months Ended
 June 30, June 30,
 1993 1992 1993 1992
 Operations Data
 Expenses:
 Research and development $1,384 $1,044 $2,563 $1,904
 General and administrative 428 329 803 721
 Interest, net (8) (121) (14) (251)
 Net loss $1,804 $1,252 $3,352 $2,374
 Net loss per share $0.32 $0.22 $0.59 $0.43
 Shares used in calculating
 per share data 5,668 5,582 5,660 5,576
 June 30, Dec. 31,
 1993 1992
 Balance Sheet Data
 Cash and short-term investments $5,680 $8,918
 Working capital 3,827 7,234
 Total assets 7,511 10,724
 Total liabilities 2,836 2,867
 Shareholders' equity 4,675 7,857
 -0- 7/22/93
 /CONTACT: Joan Shields, investor relations, or John Varian, CFO, of Anergen, 415-361-8901; or Mark J. Brand or Kimberly Kraemer of Pondel Parsons & Wilkinson, 310-207-9300, for Anergen/
 (ANRG)


CO: Anergen Inc. ST: California IN: MTC SU: ERN

LS-AF -- LA035 -- 4875 07/22/93 19:13 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 22, 1993
Words:342
Previous Article:GALOOB TOYS REPORTS REDUCED SECOND QUARTER LOSS
Next Article:TSI ANNOUNCES FIRST-QUARTER RESULTS
Topics:


Related Articles
ANERGEN PUBLISHES DETAILS OF SUCCESSFUL ANIMAL STUDIES FOR MULTIPLE SCLEROSIS THERAPY
ANERGEN REPORTS THIRD QUARTER RESULTS
ANERGEN REPORTS FISCAL 1992 RESULTS
ANERGEN REPORTS FIRST QUARTER RESULTS
ANERGEN REPORTS SECOND QUARTER 1996 RESULTS
Corixa Corporation to Acquire Anergen, Inc.
Corixa Reports Fourth Quarter and Year End Results.
Corixa Reports First Quarter Results.
Corixa Reports Strong Third Quarter Results.
Corixa Reports Fourth Quarter And Year End Results.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters